ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,828, issued on Nov. 11, was assigned to Incyte Corp. (Wilmington, Del.).

"Bicyclic amines as CDK2 inhibitors" was invented by Yingda Ye (Wilmington, Del.), Zhenwu Li (Wilmington, Del.), Ding-Quan Qian (Newark, Del.), Sarah Winterton (Wilmington, Del.), Kaijiong Xiao (Clark, N.J.), Liangxing Wu (Wilmington, Del.), Wenqing Yao (Chadds Ford, Pa.), Joshua Hummel (Hockessin, Del.), Meizhong Xu (Hockessin, Del.), Min Ye (Garnet Valley, Pa.), Yingnan Chen (Wilmington, Del.), Margaret Favata (North East, Md.) and Yvonne Lo (Hockessin, Del.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application provides bicyclic amines that are inhibitors of ...